Patient Information Feedback Radiation Exposure from Iodine-131
   
 
www.iodine131.com Homepage Scientific Information for Health Professionals
How Can I Help My Patients
And Community?

Determine Who’s At Risk | Clinical Evaluation | Risk Communication | Specialists | Treatment and Management


Determine Who’s At Risk

Incidence of thyroid cancer depends on many factors,
including thyroid dose and age at the time of exposure.


Epidemiologic studies on thyroid cancer and I-131 at Chernobyl confirmed that the risk for thyroid cancer is dependent on the absorbed dose, the age and location of persons at time of exposure, and the absence of immediate iodine prophylaxes for I-131 exposure.

A strong relationship exists among the incidences of thyroid neoplasia, hypothyroidism, and autoimmune thyroiditis and the received dose. In the most contaminated area after the nuclear release at Chernobyl, thyroid cancer incidence was significantly higher compared with other regions. There are no earlier studies comparable to those for Chernobyl because no studies were conducted around U.S. weapon production facilities when I-131 was released. The Hanford Thyroid Disease Study, released in June 2002, found no statistically significant association between I-131 dose to the thyroid from radiation released at the Hanford Nuclear Reservation and any of twelve different thyroid disease outcomes.

Children are the most sensitive group for exposure to I-131.


Age is a factor for exposure to I-131 because of the differences between thyroid doses for children and adults. The dose to children is much higher than that to adults because the thyroid mass in children is smaller, and because milk, as the main route of contamination, is consumed in higher quantities during childhood. For an equivalent uptake of I-131, a child’s thyroid receives a higher radiation dose because the same amount of energy is deposited in a smaller tissue mass (more energy per gram = higher dose). For newborns, the thyroid dose is about 16 times higher than that for adults for the same ingested radioactivity; similarly, the absorbed dose is about 8 times higher for children under 1 year old and 4 times higher for children 5 years old.

Special considerations exist for pregnant and nursing mothers.


During pregnancy, the maternal thyroid has an increased ratio of I-131 uptake, especially during the first trimester. I-131 crosses the placental barrier. During the second and third trimesters, the fetal thyroid takes up and stores iodine in increasing amounts. During the first postpartum week, thyroid activity increases up to fourfold. This critical period lasts for a couple of days. Infants and children are at high risk from radioiodine exposure because their thyroids are small. This risk decreases as children age, although it continues until they are about 20 years old. About one-quarter of the iodine ingested by the mother is secreted in breast milk, which adds an additional risk factor for the breast-feeding infant.

Drinking fresh versus pasteurized milk leads to a higher dose of I-131.


The geographic distribution of persons exposed to I-131 is important for three reasons. First, the risk is higher for those in rural areas because fresh milk is often consumed. This is important when the milk is produced from a contaminated pasture. The delay between the production and consumption of milk contributes to decreasing radioactivity for urban populations. Second, the risk is higher for populations with endemic deficiency of iodine. I-131 absorption is higher for these populations. Third, different types of milk and dairy products are consumed in some rural areas. In goat’s milk and sheep’s milk, I-131 concentrations are up to 10 times higher than in cow’s milk for the same concentration of I-131 in the pasture.

Thyroid Evaluation of Patients Who are Concerned About Hanford Iodine-131 Releases: A Guide for Physicians

Individual Dose and Risk Calculator for Nevada Test Site Fallout (National Cancer Institute)
 

 
A.C.P.M.

Produced by the American College of Preventive Medicine
with support from the Agency for Toxic Substances and Disease Registry